Sex, drugs and social connectedness: wellbeing among HIV-positive gay and bisexual men who use party-and-play drugs.


Journal Article

Background This paper explores associations between use of party-and-play drugs, including crystal methamphetamine, and wellbeing among HIV positive gay and bisexual men (GBM) in Australia. This study considers whether use of drugs in a social or sex-based setting facilitates access to social and support networks, which may in turn support wellbeing. METHODS:A cross-sectional survey of Australian people living with HIV (PLHIV) was conducted. There were 714 participants (79.7%) who identified as GBM. Differences between party-and-play drug users and non-users were examined using bivariate and multinomial logistic regressions. Mediation analysis examined the indirect effect of drug use on wellbeing via social connectedness and support. RESULTS:One in three participants (29.7%) reported party-and-play drug use within the past 12 months. Only 5% reported regular use. There were no differences between users and non-users on self-reported measures of general health, wellbeing or general social support. Compared with non-users, party-and-play drug users reported higher levels of resilience and lower levels of perceived HIV-related stigma. This was associated with spending more time with other people living with HIV and friends in the gay and lesbian community. CONCLUSIONS:While party-and-play drug use poses risks to the health of GBM, the social contexts in which these drugs are used may provide wellbeing benefits, particularly for HIV-positive GBM who may be subject to HIV-related stigma in other settings. Further research is needed to determine whether drug-use facilitates access to social networks or if people with more active social ties are more likely to engage in drug use.

Full Text

Cited Authors

  • Power, J; Miko┼éajczak, G; Bourne, A; Brown, G; Leonard, W; Lyons, A; Dowsett, GW; Lucke, J

Published Date

  • April 2018

Published In

Volume / Issue

  • 15 / 2

Start / End Page

  • 135 - 143

PubMed ID

  • 29544599

Pubmed Central ID

  • 29544599

Electronic International Standard Serial Number (EISSN)

  • 1449-8987

International Standard Serial Number (ISSN)

  • 1448-5028

Digital Object Identifier (DOI)

  • 10.1071/sh17151


  • eng